(Q35692392)

English

Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer (English)

1 reference

Europe PubMed Central

9 August 2017

1 reference

based on heuristic

inferred from title

author name string

Tamara Shenkier

1

1 reference

Europe PubMed Central

9 August 2017

Lorna Weir

2

1 reference

Europe PubMed Central

9 August 2017

Mark Levine

3

1 reference

Europe PubMed Central

9 August 2017

Ivo Olivotto

4

1 reference

Europe PubMed Central

9 August 2017

Timothy Whelan

5

1 reference

Europe PubMed Central

9 August 2017

Leonard Reyno

6

1 reference

Europe PubMed Central

9 August 2017

Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer

7

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

9 August 2017

Canadian Medical Association Journal

1 reference

Europe PubMed Central

9 August 2017

170

1 reference

Europe PubMed Central

9 August 2017

983-994

1 reference

Europe PubMed Central

9 August 2017

6

1 reference

Europe PubMed Central

9 August 2017

Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAK

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Primary systemic therapy in operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Locally advanced breast carcinoma: results with combined regional therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Local control of operable breast cancer after radiotherapy alone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Results of mastectomy and postoperative irradiation in the management of locoregionally advanced carcinoma of the breast.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

The effect of systemic therapy on local-regional control in locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

12 July 2018

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

25 September 2018

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=359433

15 November 2018

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for localy advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rules of evidence and clinical recommendations on the use of antithrombotic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen versus chemotherapy as adjuvant treatment in stage III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally advanced breast cancer: early results of a randomised trial of multimodal therapy versus initial hormone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postmastectomy radiation: a modest benefit prevails for high risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/15023926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1503/CMAJ.1030944

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35692392&oldid=1583917121"